Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell analysis of emergent haematopoiesis in the human fetal bone marrow (SS2)

ABSTRACT: Single cell analysis of emergent haematopoiesis in the human fetal bone marrow (SS2)

PROVIDER: PRJEB41521 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR4872790_1.fastq.gz	Fastqsanger.gz
	ERR4872790_2.fastq.gz	Fastqsanger.gz
	ERR4872800_1.fastq.gz	Fastqsanger.gz
	ERR4872800_2.fastq.gz	Fastqsanger.gz
	ERR4872810_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 972

Similar Datasets

Single cell analysis of emergent haematopoiesis in the human fetal bone marrow (SS2)

Project description:Haematopoeisis emerges in the human fetal bone marrow (BM) at around 12 post conception weeks. This constitutes the second wave of definitive haematopoiesis following on from the first wave in fetal liver from around 6 post conception weeks. The BM emerges as the dominant site of haematopoiesis, responsible for lifelong blood and immune cell production. Yet, little is known about how the composition of the fetal BM, the microenvironment permissive to establishing haematopoiesis and the interplay with other sites of fetal haematopoiesis in fetal health or disease. Herein we utilise single cell RNA sequencing to describe fetal haematopoeisis throughout gestation and better understand the development of the human immune system.

2021-07-15 | E-MTAB-9801 | biostudies-arrayexpress

Single cell analysis of emergent haematopoiesis in the human fetal bone marrow (10X)

2021-07-06 | E-MTAB-9389 | biostudies-arrayexpress

Single cell analysis of emergent haematopoiesis in the human fetal bone marrow (10X)

Project description:Haematopoeisis emerges in the human fetal bone marrow (BM) at around 12 post conception weeks. This constitutes the second wave of definitive haematopoiesis following on from the first wave in fetal liver from around 6 post conception weeks. The BM emerges as the dominant site of haematopoiesis, responsible for lifelong blood and immune cell production. Yet, little is known about how the composition of the fetal BM, the microenvironment permissive to establishing haematopoiesis and the interplay with other sites of fetal haematopoiesis in fetal health or disease. Herein we utilise single cell RNA sequencing and surface protein characterisation using CITE-seq technology to describe fetal haematopoeisis throughout gestation and better understand the development of the human immune system.

2021-07-15 | E-MTAB-10042 | biostudies-arrayexpress

Single cell analysis of emergent haematopoiesis in the human fetal bone marrow

Project description:Single cell analysis of emergent haematopoiesis in the human fetal bone marrow

| PRJEB42709 | ENA

Single cell analysis of emergent haematopoiesis in the human fetal bone marrow (10X)

Project description:Single cell analysis of emergent haematopoiesis in the human fetal bone marrow (10X)

| PRJEB39609 | ENA

Blood and immune cell development in human fetal bone marrow and in Down syndrome

Project description:Throughout postnatal life, haematopoiesis in the bone marrow (BM) maintains blood and immune cell production. Haematopoiesis first emerges in human BM at 11-12 post conception weeks while fetal liver (FL) haematopoiesis is still expanding. Yet, almost nothing is known about how fetal BM evolves to meet the highly specialised needs of the fetus and newborn infant. Here, we detail the development of fetal BM including stroma using single cell RNA-sequencing. We find that the full blood and immune cell repertoire is established in fetal BM in a short time window of 6-7 weeks early in the second trimester. Fetal BM promotes rapid and extensive diversification of myeloid cells, with granulocytes, eosinophils and dendritic cell subsets emerging for the first time. B-lymphocytes expansion occurs, in contrast with erythroid predominance in FL at the same gestational age. We identify transcriptional and functional differences that underlie tissue-specific identity and cellular diversification in fetal BM and FL. Finally, we reveal selective disruption of B-lymphocyte, erythroid and myeloid development due to cell intrinsic differentiation bias as well as extrinsic regulation through an altered microenvironment in the fetal BM from constitutional chromosome anomaly Down syndrome during this crucial developmental time window.

2021-07-09 | GSE166895 | GEO

Quantitative extracellular proteome analysis of fetal liver and adult bone marrow

Project description:We describe the proteomic composition of the extracellular environment of fetal and adult hematopoietic progenitors by data-independent acquisition mass spectrometry analysis.

2024-04-02 | PXD042251 | Pride

Distinct bone marrow blood vessels differentially regulate haematopoiesis.

Project description:Bone marrow endothelial cells (BMECs) form a network of blood vessels that regulate both leukocyte trafficking and haematopoietic stem and progenitor cell (HSPC) maintenance. However, it is not clear how BMECs balance these dual roles, and whether these events occur at the same vascular site. We found that mammalian bone marrow stem cell maintenance and leukocyte trafficking are regulated by distinct blood vessel types with different permeability properties. Less permeable arterial blood vessels maintain haematopoietic stem cells in a low reactive oxygen species (ROS) state, whereas the more permeable sinusoids promote HSPC activation and are the exclusive site for immature and mature leukocyte trafficking to and from the bone marrow. A functional consequence of high permeability of blood vessels is that exposure to blood plasma increases bone marrow HSPC ROS levels, augmenting their migration and differentiation, while compromising their long-term repopulation and survival. These findings may have relevance for clinical haematopoietic stem cell transplantation and mobilization protocols.

| S-EPMC6450701 | biostudies-literature

Streptococcus suis strain:SS2-1

Project description:Streptococcus suis SS2-1

| PRJNA354204 | ENA

Aquimarina sp. SS2-1

Project description:Aquimarina sp. SS2-1 Genome sequencing

| PRJNA1162685 | ENA